Literature DB >> 15530644

The multispecific organic anion transporter family: properties and pharmacological significance.

Hiroki Miyazaki1, Takashi Sekine, Hitoshi Endou.   

Abstract

Physiological and pharmacological studies indicate that the renal and hepatic organic anion transport systems are responsible for the elimination of numerous compounds, such as drugs, environmental substances and metabolites of both endogenous and exogenous origins. Recently, the molecular identity of the organic anion transport system, the OAT family, was revealed. To date, six OAT members have been identified and shown to have important roles not only in detoxification in the kidneys, liver and brain, but also in the reabsorption of essential compounds such as urate. The OAT family members are closely associated with the pharmacokinetics, drug-drug interactions and toxicity of anionic substances such as nephrotoxic drugs and uremic toxins. The molecular characterization of the OAT family encoded by SLC22A will be discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15530644     DOI: 10.1016/j.tips.2004.10.006

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  21 in total

Review 1.  Modeling kinetics of subcellular disposition of chemicals.

Authors:  Stefan Balaz
Journal:  Chem Rev       Date:  2009-05       Impact factor: 60.622

2.  Structure and function of the reduced folate carrier a paradigm of a major facilitator superfamily mammalian nutrient transporter.

Authors:  Larry H Matherly; Zhanjun Hou
Journal:  Vitam Horm       Date:  2008       Impact factor: 3.421

3.  HIV and HCV Medications in End-Stage Renal Disease.

Authors:  Keiko I Greenberg; Mark A Perazella; Mohamed G Atta
Journal:  Semin Dial       Date:  2015-04-06       Impact factor: 3.455

4.  Elucidation of common pharmacophores from analysis of targeted metabolites transported by the multispecific drug transporter-Organic anion transporter1 (Oat1).

Authors:  Valentina L Kouznetsova; Igor F Tsigelny; Megha A Nagle; Sanjay K Nigam
Journal:  Bioorg Med Chem       Date:  2011-04-28       Impact factor: 3.641

5.  Torsemide renal clearance and genetic variation in luminal and basolateral organic anion transporters.

Authors:  Stefan V Vormfelde; Markus Schirmer; Yohannes Hagos; Mohammad R Toliat; Sabine Engelhardt; Ingolf Meineke; Gerhard Burckhardt; Peter Nürnberg; Jürgen Brockmöller
Journal:  Br J Clin Pharmacol       Date:  2006-09       Impact factor: 4.335

Review 6.  Antibiotic dosing in critically ill patients with acute kidney injury.

Authors:  Rachel F Eyler; Bruce A Mueller
Journal:  Nat Rev Nephrol       Date:  2011-02-22       Impact factor: 28.314

7.  Renal transport of adefovir, cidofovir, and tenofovir by SLC22A family members (hOAT1, hOAT3, and hOCT2).

Authors:  Yuichi Uwai; Hiroki Ida; Yoshie Tsuji; Toshiya Katsura; Ken-Ichi Inui
Journal:  Pharm Res       Date:  2007-02-15       Impact factor: 4.200

8.  Molecular and functional identification of organic anion transporter isoforms in cultured bovine mammary epithelial cells (BME-UV).

Authors:  M M Al-Bataineh; D Van Der Merwe; B D Schultz; R Gehring
Journal:  J Vet Pharmacol Ther       Date:  2011-05-30       Impact factor: 1.786

Review 9.  Molecular insights into the structure-function relationship of organic anion transporters OATs.

Authors:  Fanfan Zhou; Guofeng You
Journal:  Pharm Res       Date:  2006-11-14       Impact factor: 4.200

10.  Progesterone inhibits folic acid transport in human trophoblasts.

Authors:  Elisa Keating; Pedro Gonçalves; Clara Lemos; Fernanda Costa; Isabel Campos; Sylvia B Smith; Christy C Bridges; Fátima Martel
Journal:  J Membr Biol       Date:  2007-08-09       Impact factor: 1.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.